Campylobacter jejuni (Jones et al.) Veron and Chatelain (ATCC® BAA-2151)

Strain Designations: 81-176  /  Type Strain: no  /  Biosafety Level: 2

Permits And Restrictions

View Permits

Strain Designations 81-176
Application
Emerging infectious disease research
Enteric Research
Isolation
Human patient during clinical trial
By the Center for Vaccine Development (CVD)
Type Strain no
Biosafety Level 2

Biosafety  classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country.

Product Format freeze-dried
Preceptrol® no
Genome Sequenced Strain

Campylobacter jejuni subsp. jejuni 81-176, complete genome

Type Strain no
Comments
Genome sequenced strain
Medium ATCC® Medium 260: Trypticase soy agar/broth with defibrinated sheep blood
Growth Conditions
Temperature: 37°C
Atmosphere: Microaerophilic (3-5% O2-10% CO2)
Name of Depositor P Guerry-Kopecko
Isolation
Human patient during clinical trial
By the Center for Vaccine Development (CVD)
References

Russell RG, et al. Experimental Campylobacter jejuni infection in Macaca nemestrina. Infect. Immun. 57(5): 1438-1444, 1989. PubMed: 2707853

Cross References

Nucleotide (GenBank) : CP000538 Campylobacter jejuni subsp. jejuni 81-176, complete genome

Nucleotide (GenBank) : CP000549 Campylobacter jejuni subsp. jejuni 81-176 plasmid pTet, partial sequence

Nucleotide (GenBank) : CP000550 Campylobacter jejuni subsp. jejuni 81-176 plasmid pVir, complete sequence

Notice: Necessary PermitsPermits

These permits may be required for shipping this product:

  • Customers located in the state of Hawaii will need to contact the Hawaii Department of Agriculture to determine if an Import Permit is required. A copy of the permit or documentation that a permit is not required must be sent to ATCC in advance of shipment.
Basic Documentation